Alterations of the Myristoylated, Alanine-Rich C Kinase Substrate in Prefrontal Cortex in Schizophrenia

Pinner AL, Haroutunian V, and Meador-Woodruff JH: Alterations of the Myristoylated, Alanine-Rich C Kinase Substrate (MARCKS) in Prefrontal Cortex in Schizophrenia. Schizophrenia Research. In press.

Synaptic stress and pathogenesis of neuropsychiatric disorders

J.C. Hammond, D. Shan, J. H. Meador-Woodruff, and R. E. McCullumsmith. (2013). Evidence of glutamatergic dysfunction in the pathophysiology of schizophrenia.In M. Popoli, D. Diamond, G. Sanacora (Eds.), Stress at the Synaptic Level: Synaptic stress and pathogenesis of neuropsychiatric disorders. New York, NY: Springer Science.+Business Media, LLC. In press

Abnormal Partitioning of Hexokinase 1 Suggests Disruption of a Glutamate Transport Protein Complex in Schizophrenia.

Shan D, Mount D, Moore S, Haroutunian V, Meador-Woodruff JH, and McCullumsmith RE:  Abnormal Partitioning of Hexokinase 1 Suggests Disruption of a Glutamate Transport Protein Complex in Schizophrenia.  Schizophrenia Research. In press.

N-Glycosylation of GABAA Receptor Subunits is Altered in Schizophrenia

Mueller TM, Haroutunian V, and Meador-Woodruff JH. (2013) N-Glycosylation of GABAA Receptor Subunits is Altered in Schizophrenia. Neuropsychopharmacology. 39, 528–537.

Alteration of cyclic-AMP response element binding protein in the postmortem brain of subjects with bipolar disorder and schizophrenia.

Ren X, Rizavi HS, Khan MA, Bhaumik R, Dwivedi Y, Pandey GN. Alteration of cyclic-AMP response element binding protein in the postmortem brain of subjects with bipolar disorder and schizophrenia. J Affect Disord. 2014 Jan;152-154:326-33.

Read more...

Bipolar CHOICE: An illustration of a comparative effectiveness trial for a complex disorder

Nierenberg, A.A., Sylvia, L.G., Leon, A.C., Reilly-Harrington, N.A., Shesler, L.W., McElroy, S.L., Friedman, E.S., Thase, M.E., Shelton, R.C., Bowden, C., Tohen, M., Singh, V., Deckersbach, T., Ketter, T., Kocsis, J.H., McInnis, M.G., Schoenfeld, D., Bobo, W.V., Calabrese, J.R., Bipolar CHOICE Study Group. Bipolar CHOICE: An illustration of a comparative effectiveness trial for a complex disorder. Clinical Trials (in press).

Read more...

BDNF, interleukin-6, and salivary cortisol levels in depressed patients treated with desvenlafaxine.

Ninan P.T., Shelton R.C., Bao W., Guico-Pabia C.J. BDNF, interleukin-6, and salivary cortisol levels in depressed patients treated with desvenlafaxine. Progr Neuropsychopharmacol Biol Psychiatry (in press).

Read more...

The effect of regulatory advisories on maternal antidepressant prescribing

Bobo W.V., Epstein R.A. Jr, Hayes R.M., Shelton R.C., Hartert T.V., Mitchel E., Horner J., Wu P. The effect of regulatory advisories on maternal antidepressant prescribing, 1995-2007: an interrupted time-series study of 228,876 pregnancies Archives of Womens Mental Health 17:17–26, 2014


Read more...

Association of exercise with quality of life and mood symptoms in a comparative effectiveness study of bipolar disorder

Sylvia LG, Friedman ES, Kocsis JH, Bernstein EE, Brody BD, Kinrys G, Kemp DE, Shelton RC, McElroy SL, Bobo WV, Kamali M, McInnis MG, Tohen M, Bowden CL, Ketter TA, Deckersbach T, Calabrese JR, Thase ME, Reilly-Harrington NA, Singh V, Rabideau DJ, Nierenberg AA. Association of exercise with quality of life and mood symptoms in a comparative effectiveness study of bipolar disorder. Journal of Affective Disorders (in press).

Read more...

Differential change in specific depressive symptoms during antidepressant medication or cognitive therapy

Fournier J.C., DeRubeis R.J., Hollon S.D., Gallop R., Shelton R.C., Amsterdam J.D. Differential change in specific depressive symptoms during antidepressant medication or cognitive therapy. Behaviour Research and Therapy (in press).

Read more...